Women have long faced more challenges than men while making their way to the uppermost ranks of prominent companies. And it’s ...

Several major companies are appointing industry veterans as CEOs to address investor concerns. Notable appointments include ...

Major companies are recalling former executives to helm leadership roles, aiming to address investor apprehensions over ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CVS stock, giving a Buy rating today. Ann Hynes has given her Buy ...

NEW YORK (Reuters) - As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on ...

David Joyner已成为CVS健康(NYSE:CVS)的新任CEO，在Karen Lynch上周五离职后接任。华尔街分析师和一些投资者对Joyner能否解决困扰Aetna健康保险业务的高医疗成本问题表示担忧。Joyner自2023年起负责CVS的Caremark药房福利管理业务，上周三由董事会任命。 这次领导层变动恰逢CVS撤回2024年盈利预测，并宣布第三季度利润将大幅低于分析师预期，导致 ...

That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer ...

The industry-wide rise in health coverage costs makes the company's Aetna unit the new leader's most difficult problem.

As CVS Health's new CEO David Joyner steps into the top job, Wall Street analysts and some investors are questioning whether ...

Piper Sandler重申了对CVS Health (NYSE:CVS)的增持评级，目标价保持在72.00美元。该公司的立场是在CVS Health宣布2024年第三季度医疗损失率（MLR）和每股收益（EPS）显著低于预期，并撤回2024年全年指引后做出的。为迅速应对这些挑战，CVS Health任命David Joyner为新任首席执行官，即刻生效。

As the new CEO at CVS, Joyner’s strategic partner will be CFO Tom Cowhey, who was promoted to the role in January after ...

在Karen Lynch上周五迅速离职后， 西维斯健康 (CVS.US)新任首席执行官David Joyner接任首席执行官一职。华尔街分析师和一些投资者质疑，在安泰医疗保险公司 ...